<DOC>
	<DOC>NCT00503022</DOC>
	<brief_summary>This study evaluates the tolerability and safety of a single intravenous infusion of ACZ885. It also explores the efficacy of the compound in central macular edema and visual acuity in patients with wet age-related macular edema.</brief_summary>
	<brief_title>Safety and Tolerability of an Intravenous Infusion of ACZ885 in Patients With Wet Age-Related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<criteria>Inclusion criteria: Male or female â‰¥ 50 years old, with aged related macular degeneration Patients with subfoveal choroidal neovascularization secondary to agerelated macular degeneration Exclusion criteria: Active intraocular inflammation or ocular infection in the study eye Eye disease that may result in visual loss during the study Chronic therapy with topical, local or systemic corticosteroids. Pregnant or nursing (lactating) women.</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Wet age-related macular degeneration</keyword>
	<keyword>ACZ885</keyword>
</DOC>